Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that

Related Keywords

Pulmonx Zephyr ,Mehul Joshi ,Brian Johnston ,Gilmartin Group ,Pulmonx Corporation ,Pulmonx Corporation Nasdaq ,Compensation Committee ,Chief Financial Officer ,Nasdaq Listing Rule ,Incentive Plan ,Endobronchial Valve ,Pulmonary Assessment System ,Lung Analysis Platform ,Zephyr Valve ,Zephyr Valves ,Region ,